SRN Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,280
Closed -$993K 96
2023
Q3
$993K Buy
2,280
+74
+3% +$33.6K 0.98% 40
2023
Q2
$980K Sell
2,206
-44
-2% -$20.3K 0.87% 57
2023
Q1
$1.03M Sell
2,250
-7
-0.3% -$3.33K 0.95% 53
2022
Q4
$1.16M Buy
+2,257
New +$1.15M 1.15% 42

Other funds holding ELV

SRN Advisors's ELV Position: Q4 2023 in Review

SRN Advisors sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 2,280 shares — an estimated $993K sold.

SRN Advisors first reported a position in ELV in Q4 2022 and held it in 4 quarters. The position peaked at $1.16M in Q4 2022. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • SRN Advisors reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • SRN Advisors sold 2,280 Elevance Health shares in Q4 2023, an estimated $993K.
  • SRN Advisors first reported a position in Elevance Health in Q4 2022 and held it in 4 quarters.
  • SRN Advisors's Elevance Health position peaked at $1.16M in Q4 2022.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on SRN Advisors's 13F filing for Q4 2023, filed 14 Jun 2024.